Where investing is concerned, it’s time to shift away from ideology. Instead, look to the intersection of social and economic ...

Short-selling is an interesting part of the stock market that can be dangerous and even controversial. Investors selling ...

By Leah Concialdi Photos by Brian Greenblatt and Joseph Baura As a mysterious synth tone filled the air, Lettuce commenced their set with "Trapezoid," the lead track off of their 2019 GRAMMY-nominated ...

CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...

Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical ...

He was 84. The director of more than 20 films, including “Xica da Silva” and “Bye Bye Brazil,” Diegues was a leading figure in Cinema Novo, a movement that emerged in the 1960s and used film to ...

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force behind its strong numbers. It may not be long before Novo Nordisk also ...

Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and weight loss drug participated in unlawful business practices. The ...

Novo Nordisk (NYSE: NVO) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, beginning with a 3% decline on Monday from last Friday's close, and falling ...

Enrico Cañal Bruland, left, GM of Novo Nordisk Pharma Thailand, and Danish Ambassador Danny Annan cut the ribbon to mark the opening of the company’s newly ...

What’s going on here? Volvo gained full control of Novo Energy's battery project without any payment to Northvolt, following Northvolt's bankruptcy issues. Volvo strategically obtained a 50% stake in ...